Affiliate disclosure: some links on this page are affiliate links and may earn us a commission at no extra cost to you — it never affects our rankings or reviews.
Guide · Sermorelin · US
Sermorelin cost: what it costs to buy online in the US
Sermorelin is sold online in the US as a prescription subscription, mostly as an injection you give yourself and in some places as a tablet. Online it costs from $79 to $219 a period, depending on the provider, the route and how long you commit for, and almost every advertised figure carries a condition. This page puts every published price in one table, each read from the provider's own live page, with the date we read it and a link so you can check.
The short version
- Injections run $99 to $219 and tablets $79 to $159, across the four providers below that publish a price. Three bill monthly and one every 4 weeks.
- Every headline figure carries a condition. bmiMD's lowest price is a 6-month plan, Embody's $99 sits under a sale banner, Luvo Health's $99.50 covers the first 4 weeks only, and System Labs' $109 is a first month, with a live price test showing some visitors a different figure.
- Sermorelin was FDA-approved once, as Geref, for children with growth hormone deficiency. Its maker stopped selling it in 2008, and FDA found that was not for safety or effectiveness reasons. What these providers sell is compounded.
- The evidence for adult use is thin. No systematic review of sermorelin is indexed in PubMed, and a 2026 review describes the human evidence for benefit in healthy people as limited and largely indirect.
Injection or tablet: what the choice changes
The injection is given subcutaneously, by you, on the schedule your prescriber sets. The tablets dissolve under the tongue or in the mouth and involve no needle. Two of the four providers here sell a tablet, and at both it costs less than their injection.
Neither provider publishes a comparison of how much sermorelin each route delivers, and none of the sources in the evidence section below compares them either. This page therefore does not say one route works better than the other. If the needle is the deciding factor, the tablet exists; that is what the published information supports.
If the tablet is what you want to look at, these links go to each seller's sermorelin page, the tablet page where one exists, in the table's order: bmiMD and System Labs. We earn a commission on these links, as on the partner links further down.
What sermorelin costs in the US right now
Every figure below was read from the provider's own live page on the date shown, and the page it came from is linked. Nothing here is estimated, interpolated between plan lengths, or taken from a third-party round-up. Where a provider publishes no dose or supply, the column says so rather than being filled in. Rows are ordered by route and then alphabetically, never by price.
| Provider | Route | Published price | Intro / first period | Dose or supply | Read on |
|---|---|---|---|---|---|
| bmiMDMail-order telehealth | Injection | $99 per month | Not published | One 5 mL vial (2mg/mL, 10mg total), stated as a 1 month supply of approx 30 injections | September 25, 2026 |
| EmbodyMail-order telehealth | Injection | $99 per month | Not published | Not published | September 25, 2026 |
| Luvo HealthMail-order telehealth | Injection | $199 every 4 weeks | $99.50 for the first 4 weeks | Not published | September 25, 2026 |
| System LabsMail-order telehealth | Injection | $219 per month | $109 first month | Monthly supply stated as 9mg | September 25, 2026 |
| bmiMDMail-order telehealth | Sublingual tablet | $79 per month | Not published | Not published | September 25, 2026 |
| System LabsMail-order telehealth | Oral dissolving tablet | $159 per month | $79 first month | Monthly supply stated as 1000mcg | September 25, 2026 |
- bmiMD, injection: $99 is the lowest of three published subscription tiers, and it is the 6-month plan ($594 in total). bmiMD publishes $99/mo (6 month), $119/mo (3 month, $357 in total) and $139/mo (1 month), each against a $149.40/mo list price. A reader who signs up month to month pays $139. Elsewhere on the same page bmiMD says "Start for $139/month. Billed quarterly, shipped monthly", which does not match the 1-month tier; both statements are on the page. The page says there are no hidden membership fees and that consultations are at no cost. Read in a rendered browser from a US connection; bmiMD serves automated requests a browser check.
- Embody, injection: Embody presents $99 as a flat rate, "Fixed price of $99/month", under a banner reading "LIMITED FALL SALE. Save $100 Every Month". That implies a $199 standing price, though no $199 figure appears on the page. A free online medical evaluation and the prescription and telemed visits are stated as included. Embody's own page says sermorelin "is not intended for anti-aging, bodybuilding, or athletic performance purposes".
- Luvo Health, injection: The product page labels $99.50 as "50% off your first 4 weeks" and reads "$199 from your second delivery". Luvo bills every 4 weeks (28 days) rather than monthly, which is 13 billing cycles a year rather than 12. The page states there are no membership fees, and that compounded medications are not FDA-approved.
- System Labs, injection: System Labs is running a live price test on this page, and each visitor is assigned one of two versions. The standard version shows "Monthly Supply (9mg)" at $219 with $109 for the first month, which is also what the page's billing answer states to every visitor: "First month is $109. After that, $219 per month." The test version shows "Quarterly Supply (9mg)" at $175 with $89 for the first month. That card does not say whether $175 is charged per month or per quarter, so it is not recorded as a price.
- bmiMD, sublingual tablet: $79 is the 6-month tier ($474 in total). bmiMD publishes $79/mo (6 month), $89/mo (3 month, $267 in total) and $99/mo (1 month), each against a $149.40/mo list price. The page states the tablets are "Available in 49 States", against "All 50 States" for the injection, and publishes no dose.
- System Labs, oral dissolving tablet: Shown as "Monthly Supply (1000mcg)" at $159 with $79 for the first month. The same price test applies here: some loads served a "Quarterly Supply (1000mcg)" version, whose price was not read today and is not recorded. Unlike the injection page, this page's billing answer states no price.
Buying sermorelin online
Four providers we work with sell sermorelin, and they are listed below in the same order as the table: alphabetically. That order is not a ranking. We earn a commission if you buy through these links, and the commission differs between providers; that changes nothing about the order, the prices above or what we publish about any of them.
bmiMD
$99 to $139 a month injected, $79 to $99 as a tablet, by plan length
Injection or sublingual tablet. Read from bmiMD's own page on .
- Three plan lengths per route, and the lowest price is the 6-month plan: injection $99, $119 or $139 a month
- Sublingual tablets $79, $89 or $99 a month on the same three plan lengths
- Injection supply published as one 5 mL vial, 10mg in total, stated as a 1 month supply
- Injection stated as available in all 50 states, tablets in 49
Embody
$99 a month, flat
Injection. Read from Embody's own page on .
- Described on the page as a "Fixed price of $99/month"
- Shown under a "Save $100 Every Month" sale banner, with no standing price published
- Free online medical evaluation, prescription and telemed visits stated as included
- Publishes no dose or supply
Luvo Health
$199 every 4 weeks, $99.50 for the first 4 weeks
Injection. Read from Luvo Health's own page on .
- Billed every 4 weeks (28 days) rather than monthly
- First 4 weeks at $99.50, labelled on the page as 50% off
- No membership fees, stated on the product page
- Luvo states that plans are set after a medical review, and that compounded medications are not FDA-approved
System Labs
$219 a month injected, $159 as a tablet, after a $109 or $79 first month
Injection or oral dissolving tablet. Read from System Labs's own page on .
- Running a live price test: some visitors are shown a $175 "Quarterly Supply" card with $89 for the first month
- Its billing answer states "First month is $109. After that, $219 per month."
- Publishes a supply for both routes: 9mg a month injected, 1000mcg a month as a tablet
- Refills are automatic, and the page says you can pause or cancel at any time
Luvo Health offer code
Luvo Health told us in writing on 24 September 2026 that the code CLINIC20 takes 20% off a 3-month supply of NAD+ or sermorelin, and that it cannot be combined with other offers. These are the terms as Luvo stated them to us; they are not published on Luvo's sermorelin page, which shows a 4-week price only, so we cannot show what a 3-month supply costs before or after the code. Confirm the discount at checkout before you pay.
Compounded medicines: what that word means here
Every sermorelin product on this page is compounded. That means it is prepared against an individual prescription by a compounding pharmacy rather than manufactured as a finished product and reviewed by the FDA. It is a distinct regulatory category: not approved, and not unlawful either.
Sermorelin is unusual in having once been an approved medicine. It was sold as Geref until its manufacturer discontinued it in 2008, and FDA later determined that the withdrawal was not for reasons of safety or effectiveness. No approved sermorelin is sold in the US today, so every option here is a compounded one, and the pharmacy that prepares it carries more of the responsibility than it would for a branded medicine. Embody's sermorelin page names its partner pharmacies. For any provider, it is worth asking which pharmacy prepares your prescription before you pay.
What the evidence shows, and what it does not
The short answer is that sermorelin was studied mainly as a treatment and a diagnostic test for children with growth hormone deficiency, and that the evidence for the adult uses it is marketed for today is thin. That is a statement about what has been studied, not a finding that sermorelin does or does not work, and each point below is taken from a source listed at the end of this section.
Regulatory history. Sermorelin acetate was approved by the FDA as Geref twice: in 1990 as a test of the pituitary gland's ability to release growth hormone, and in 1997 to treat idiopathic growth hormone deficiency in children with growth failure. The manufacturer, EMD Serono, told the FDA in 2008 that it was discontinuing both products, and the FDA withdrew both approvals effective 18 June 2009. In 2013 the FDA determined that neither product was withdrawn from sale for reasons of safety or effectiveness. FDA's drug approvals data lists no other sermorelin product, and both Geref entries are marked discontinued.
What has been studied in people. Sermorelin is the first 29 amino acids of the hormone that signals the pituitary to release growth hormone, and trials often name it by that structure, GHRH(1-29). In a 1993 randomised trial, 60 children with growth hormone deficiency received sermorelin at one of two doses, or growth hormone, for 6 months. Growth was significantly greater on growth hormone: 14.6 cm a year, against 9.2 and 9.3 cm on the two sermorelin doses. Almost every child on sermorelin, 39 of 40, developed antibodies to it, which had almost disappeared 9 months after stopping, and the authors concluded that it was unlikely to be as effective as growth hormone for promoting growth.
What has not been established. A PubMed search on 25 September 2026 found no systematic review or meta-analysis of sermorelin. A 2026 review of peptides that act on the growth hormone axis states that clinically meaningful benefits in healthy individuals remain uncertain, because the human evidence base is limited and largely indirect. It records that sermorelin has no current regulatory approval for performance or body-composition uses, and that no long-term safety data are available. A second 2026 review, covering unapproved peptides sold direct to patients as a group, describes rigorous human safety data as scarce. None of the sources here reports an effect on appearance, ageing or lifespan in adults.
What is known about side effects. The 2026 review lists injection-site pain, short-term flushing, nausea, dizziness and headache, rare allergic reaction, and a small, transient rise in the hormone prolactin. In the 1993 trial, three children reported mild irritation at the injection site and no serious side effects were seen. None of this was measured for the compounded products sold on this page, so their side effect profile is not established in either direction.
Sources for this section
- FDA, Federal Register: Determination That GEREF (Sermorelin Acetate) Injection, 0.5 Milligrams Base/Vial and 1.0 Milligrams Base/Vial, and GEREF (Sermorelin Acetate) Injection, 0.05 Milligrams Base/Amp, Were Not Withdrawn From Sale for Reasons of Safety or EffectivenessPublished ; retrieved . Records both Geref approvals (NDA 19-863, 28 December 1990, a diagnostic; NDA 20-443, 26 September 1997, for idiopathic growth hormone deficiency in children with growth failure), their discontinuation by EMD Serono in 2008, the withdrawal of both approvals effective 18 June 2009, and FDA's determination that neither was withdrawn for reasons of safety or effectiveness.
- FDA, Drugs@FDA: GEREF (sermorelin acetate), NDA 020443Published ; retrieved . The published date is the original approval date given in the Federal Register notice above. The record lists both strengths as "Discontinued". A search of FDA's drug approvals data on the retrieved date returned only the two Geref applications for sermorelin, both discontinued.
- National Library of Medicine, MeSH: SermorelinPublished ; retrieved . Defines sermorelin as GHRH(1-29)-amide, the active fragment of human growth hormone-releasing factor, used to diagnose or treat growth hormone deficiency. The published date is the year the heading was introduced. Cited so that trials naming GHRH(1-29)-NH2 can be read as trials of sermorelin.
- Acta Paediatr Suppl (PubMed 8329830): A comparative study of growth hormone (GH) and GH-releasing hormone(1-29)-NH2 for stimulation of growth in children with GH deficiencyPublished ; retrieved . A randomised trial of 60 children with growth hormone deficiency, over 6 months.
- Front Endocrinol (PMC13322892): The emerging landscape of performance-enhancing peptides modulating GH-IGF1 axis: bridging the gap between clinical evidence and patient self-administrationPublished ; retrieved . A narrative review, not a systematic one. Read in full. The authors declare no commercial or financial conflict of interest.
- Sports Med (PubMed 41966639): Safety and Efficacy of Approved and Unapproved Peptide Therapies for Musculoskeletal Injuries and Athletic PerformancePublished ; retrieved . A narrative review covering sermorelin among other peptides. Published online 12 April 2026, in the August 2026 issue. Its statement on human safety data is about the unapproved peptides it covers as a group. One author discloses consulting fees from Arthrex for unrelated work.
- PubMed (National Library of Medicine): Search: sermorelin, systematic reviews and meta-analysesPublished ; retrieved . A search, not a publication. On the date shown it returned no records: PubMed indexed no systematic review or meta-analysis of sermorelin. A search result can change as new work is indexed.
Questions to ask before you pay
- Is the advertised price the ongoing one, or a first month, a first 4 weeks or a long commitment? Every provider here quotes one of those.
- Is the plan billed monthly, every 4 weeks or quarterly, and what is the price if you stop early?
- Which compounding pharmacy prepares it, and will they name it before you order?
- What supply does the price cover, and does it change if your prescriber changes the dose?
- Is the product available in your state, and is that confirmed before payment or after?
Frequently asked questions
How much does sermorelin cost?
From the four online providers we could price on their own pages on 25 September 2026, sermorelin injections cost $99 to $219 and tablets $79 to $159, priced per month except at Luvo Health, which bills $199 every 4 weeks. Each headline figure carries a condition: bmiMD's lowest price is a 6-month plan, Embody's $99 sits under a sale banner, Luvo's $99.50 covers the first 4 weeks only, and System Labs' $109 is a first month before $219. The table on this page separates the ongoing price from the introductory one and links every figure to the page it was read from.
Can you buy sermorelin online?
Yes, in the US, through telehealth providers that sell it as a prescription after an online medical intake. It is not sold over the counter. The four providers on this page all work this way and ship to your door; the price you pay is a subscription rather than a one-off purchase. Sermorelin sold online as a "research" product is a different thing: it is not sold on prescription and is not what this page covers.
Do you need a prescription for sermorelin?
Yes. The sermorelin these providers sell is a compounded prescription medicine, prepared for an individual patient against a prescription. Each provider on this page sells it through an online medical intake reviewed by licensed providers, and none of them sells it without one.
Is sermorelin FDA-approved?
Not today. Sermorelin was approved as Geref, first in 1990 as a diagnostic test and in 1997 to treat children with growth hormone deficiency. Its manufacturer stopped selling it in 2008 and FDA withdrew both approvals in 2009. FDA later determined that Geref was not withdrawn for reasons of safety or effectiveness. No FDA-approved sermorelin is sold in the US now, so what telehealth providers prescribe is compounded.
Is sermorelin the same as HGH?
No. Sermorelin is a fragment of the hormone that signals the pituitary gland to release growth hormone, so it acts one step earlier than growth hormone itself. In a 1993 trial in children with growth hormone deficiency, growth was significantly greater on growth hormone than on sermorelin over 6 months. That trial is about children with a diagnosed deficiency, and it says nothing either way about adults using sermorelin for other reasons.
Why do sermorelin prices differ so much between providers?
Because the figures are not measuring the same thing. bmiMD's lowest price is a 6-month commitment and rises to $139 month to month. Luvo Health bills every 4 weeks, not monthly. System Labs quotes a first month before its ongoing price, and is testing a second price on some visitors. Embody's $99 is a flat rate under a sale banner. Compare the ongoing price you would actually pay, not the first figure a page shows you.
How this page was sourced
Prices come from each provider's own live page and nowhere else, and every one carries the date it was read and a link to the page it was read from. Pages that change what they show from one visitor to the next were loaded repeatedly, and where a provider is testing more than one price the note under the table says so. The one figure on this page that does not come from a public page is the Luvo Health offer code, which is reported as Luvo stated it to us, with the date. No third-party comparison site, review aggregator or press mention was used. Marketing claims, patient counts, star ratings and testimonials are excluded rather than repeated.
This page is US-facing. It reports a market; it does not recommend sermorelin, and nothing on it is medical advice or dosing guidance. Peptide Clinic Finder earns a commission if you buy through the partner links above, which is disclosed at the top of that section and does not change what we publish about any provider.